Sign Up to like & get
recommendations!
1
Published in 2020 at "Blood"
DOI: 10.1182/blood.2019003701
Abstract: Acute myeloid leukemia (AML) with inv(3)/t(3;3)(q21q26) is a distinct WHO recognized entity, characterized by its aggressive course and poor prognosis. In this subtype of AML, the translocation of a GATA2 enhancer (3q21) to MECOM (3q26)…
read more here.
Keywords:
atypical 3q26;
mecom;
mecom rearrangements;
acute myeloid ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Diagnostics"
DOI: 10.3390/diagnostics15182410
Abstract: Background/Objectives: Relapsed acute myeloid leukemia (AML) is often characterized by clonal evolution and acquired genomic abnormalities, which can inform prognosis and direct therapeutic decisions. The emergence of high-risk chromosomal rearrangements during relapse is of particular…
read more here.
Keywords:
myc mecom;
aml case;
case featuring;
case ... See more keywords